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The genetic causes of essential tremor (ET) seem to be heterogeneous. Recently, ET has been found
associated with a functional variant (Ser9Gly) of the dopamine D3 receptor (DRD3), located in the ETM1
locus on chromosome 3q13.3 described for the first time in 1997. We examined this variant in three
different populations from Germany, Denmark and France. We undertook an association study of the
Ser9Gly variant in 202 cases with a familial history from unrelated families with ET, 97 cases with isolated
non-familial ET and 528 healthy controls. In addition, linkage and segregation analyses were carried out in
22 ET families. The distribution of genotypes and allele frequencies showed no significant differences in
the whole sample and in a subanalysis of familial and sporadic cases. Age at onset of tremor, tremor
duration and tremor severity did not show an association with the genotype. In addition, the DRD3 variant
was not found linked to the disease in a subset of informative ET families. We did not find a significant
association of the DRD3 variant with ET nor linkage to the DRD3 receptor in German, Danish and French ET
patients and families, suggesting that it is unlikely to be a causal factor for ET.
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Introduction
Essential tremor (ET) is one of the most common
movement disorders and shows a heterogeneous pheno-
type. A positive family history has long been recognized
and is reported in 17–100% of ET patients.1 Segregation
analysis reveals that ET transmission might be compatible
with an autosomal-dominant mode of inheritance.2
However, a large proportion of ET patients present as
isolated cases, and in that case, ET is considered not to be
a single gene disorder but a complex disease requiring
interactions of environmental and genetics factors
with low penetrance.3 – 5 At least three chromosomal
loci (ETM) have been identified by linkage analysis so
far. ETM1 has been mapped in Icelandic families
on chromosome 3q13,6 ETM2 in North American families
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on chromosome 2p22–p257 and ETM3 has been
identified in North American families on chromosome
6p23.8
The 10 cM interval of the ETM1 region contains
approximately 70 genes according to different electronic
sources (National Centre of Biological Investigation
(NCBI); Ensembl genome browser), including the dopa-
mine D3 receptor (DRD3) gene in which three synonymous
and one non-synonymous SNP have been reported.
Linkage and association to the non-synonymous variant
(Ser9Gly, A-G) of the DRD3 gene has recently been shown
in a small sample of 30 French familial ET cases and a
larger American sample of ET patients (n¼276) with Gly
homozygous patients presented with more severe and/or
earlier onset forms of the disease.9,10 However, the effect in
the Americans was much smaller (odds ratio (OR)¼1.35
with allelic P-value¼0.039) than in the French sample
alone (OR¼2.5, allelic P-value¼0.007). Furthermore,
in vitro studies have shown an increase of the dopamine-
mediated cAMP response and of mitogen-associated
protein kinase with the G allele, so that an increase in
dopamine affinity by the Gly9 variant was hypothesized.
However, two replication studies did not find a significant
association of the Gly allele with ET in Asian11
and American samples.12 To date, the Ser9Gly DRD3
polymorphism has only been investigated in one
linkage-based study in French families9 but has not been
investigated in other European ET samples in an associa-
tion-based study design so far. Therefore, we performed
linkage and association analysis of the DRD3 variant in 299
unrelated ET index patients and 528 controls of German,
Danish and French origin.
Patients and methods
Patients
For the association study, 299 unrelated ET index patients
were included from two centres in Kiel (n¼147, including
28 Danish patients) and Paris (n¼ 52) (Table 1a and 1b).
The Danish sample was initially recruited for a twin study
of ET within the framework of the Longitudinal Study of
Aging of Danish Twins.13 All participants gave their
informed consent. This study was approved by the German
(reference no. A143/00), Danish (reference no. 20010177)
and French (reference no. 04-06-08) Ethical Committees.
Two hundred and two patients described a positive family
history (135 German; 49 French; 18 Danish).
Familial segregation and linkage analysis of the DRD3
variant was performed in 22 ET families (16 French; 4
German; 2 Danish), selected among the 202 familial cases
considering 89 definite and probably affected individuals
(66 French; 17 German; 6 Danish), 15 patients with a
possible status (8 German; 7 French) and 68 unaffected
individuals (38 French; 24 German; 6 Danish).
In 15 of these families (12 French families and 3 German
families), the intervals between markers D2S224 and D2S405
(2p22-p25; ETM2) and D6S202 and D6S289 (6p23; ETM3)
were previously excluded by haplotype reconstructions (data
not shown, ETM2: D2S224; D2S2150; D2S144; D2S405;
ETM3: D6S202; D6S1279; D6S1006; D6S289).
Table 1a Clinical characteristics of samples with familial essential tremor from three different countries
Clinical features German samples French samples Danish samples All
Number of index cases 135 49 18 202
Men/women 88/47 22/27 9/9 119/83
Age at examination, years,
mean±SD (range)
59.1±14.6 (18–84) 52.9±18.6 (19–84) 75.2±5.1 (70–89) 58.7±16.1 (18–89)
Age at onset, years, mean±SD (range) 29.7±19.2 (5–75) 28.6±19.2 (5–70) NA 29.4±19.2 (5–75)
AA 29±19.3 (5–74) 27.4±21.6 (5–70) NA
AG 30.2±19.2 (5–75) 29.1±18.4 (6–60) NA
GG 30.2±20.4 (2–65) 31.3±18.7 (14–56) NA
Tremor severitya, mean±SD (range)b 7.2±3.7 (2–21) 11.5±6.2 (2–26) 7.1±2.6 (3–12) 8.2±4.7 (2–26)
AA 7.4±3.3 (3–17) 8.1±5.7 (2–22) 5.3±1.8 (3–8)
AG 7.5±4.2 (2–21) 13.5±6 (3–26) 7.8±2.3 (5–11)
GG 5±1.2 (4–8) 13.3±4.2 (10–18) 9.3±3.1 (6–12)
Tremor duration, years, mean±SD (range) 28.4±16.3 (5–60) 25.8±15.5 (3–69) X 27.6±16.1 (3–69)
AA 31±16.9 (7–60) 29.4±18.5 (3–69) X
AG 28.1±16.7 (5–60) 23.2±13.3 (7–55) X
GG 21.7±11.9 (5–40) 27±16.1 (14–50) X
Alcohol responsiveness of tremor (%) 81 (60) NA 7 (38.9) 88 (43.6)
NA, not available.
aBy Part A of the Fahn–Burke–Marsden tremor scale 16, X in all Danish twins tremor duration Z5 years.
bNo significant difference among each nation.
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Controls There were 528 unrelated healthy controls, 299
men and 229 women. They were from Germany (n¼311,
mean age at examination 68.8±5.5 years),14 from
Denmark (n¼52, aged above 69 years at the time of
examination) and from France (n¼165, mean age at
examination 63.2±9.2 years). None of the controls showed
any clinical signs of ET. All controls were screened negative
for ET either by a screening procedure for ET (all Danish
and German controls, n¼311)15 or they underwent a
neurological examination (all French controls).
Neurological examination and tremor diagnosis
The clinical visits included anamnestic data on age at onset
(AAO), duration and family history of tremor and a
complete neurological examination by a movement
disorders specialist. Tremor severity was rated by using
the Fahn–Tolosa–Marin tremor scale, part A.16 ET was
diagnosed on the three levels of certainty as defined by the
consensus criteria of the Tremor Investigation Group.17
Only patients with definite and probable ET were included
in the genetic analysis. Familial ET was defined as the
presence of at least another first-degree relative of the
index case affected with ET.
DRD3 genotyping and sequencing
DNA was extracted from blood samples using a standard
protocol. Genotyping of the Gly9Ser variant (rs 6280), in
the coding region of the DRD3 receptor, was performed in
German and Danish unrelated ET patients (n¼247) and all
528 controls for the association study. In the 52 French
index patients, all 7 coding exons of the DRD3 gene and
their flanking splice sites with at least 50 bp of intronic
sequence on each side were sequenced.
Briefly, samples were PCR amplified with ABI 9700 PCR
machines (Applied Biosystems, Foster City, USA). TaqMan
SNP genotyping assay on ABI 7900 fluorometers or direct
sequencing using the BigDye chemistry on ABI 3730 were
used according to the instructions of the manufacturer
(Applied Biosytems) as previously described.18 – 20 PCR
primers and annealing conditions are available on request.
Microsatellite genotyping
For linkage analysis, four microsatellite markers (ETM1:
D3S1552; D3S3652; D3S1278; D3S3641) covering a
segment of approximately 45 cM including the ETM1
region,6 centred on marker D3S1267, were amplified using
one fluorescently labeled primer, and the fragments were
resolved on an ABI-3730 sequencer (Applied Biosystems).
Genotypes were determined with GeneMapper 4.0
software (Applied Biosystems).
Statistical analysis
The genotype and allele frequency between ET cases and
controls were compared using the w2-test. Both groups were
tested for Hardy–Weinberg equilibrium. Statistical signifi-
cance was defined at Po0.05. Analysis of variance was used
to test for statistical significance for the between-patient
factor ‘genotype’ and the within-patient factors ‘age of
Table 1b Clinical characteristics of samples with ‘apparently’ sporadic essential tremor from three different countries
Clinical features German samples French samples Danish samples All
Number of index cases 84 3 10 97
Men/women 49/35 2/1 6/4 57/40
Age at examination, years,
mean±SD (range)
61±15.7 (17–91) 77±1.4 (76–78) 75.9±5.6 (70–86) 62.4±15.7 (17–91)
Age at onset, years,
mean±SD (range)
30.2±20.9 (2–80) 42±31.1 (20–64) NA 30.6±21.1 (2–80)
AA 29.4±19.9 (10–75) 42±31.1 (20–64) NA
AG 32.7±21.7 (5–80) F NA
GG 22.4±25.2 (2–65) F NA
Tremor severitya, mean±SD (range)b 7.3±4.2 (2–26) 17.5±0.7 (17–18) 5.4±1.9 (3–8) 7.4±4.3 (2–26)
AA 7.4±4.8 (3–26) 17.5±0.7 (17–18) 5.7±2.1 (3–8)
AG 7.2±3.6 (2–16) F 7±0 (7)
GG 8±3.3 (4–13) F 4±0 (4)
Tremor duration, years,
mean±SD (range)
29.4±18.4 (5–70) 35±32.5 (12–58) X 29.5±18.6 (5–70)
AA 30.9±18.2 (5–70) 35±32.5 (12–58) X
AG 27.2±19.4 (5–60) F X
GG 31.4±16.9 (12–50) F X
Alcohol responsiveness of tremor (%) 35 (41.7) NA 5 (55.5) 40 (42.1)
NA, not available.
aBy Part A of the Fahn–Burke–Marsden tremor scale 16, X in all Danish twins tremor duration Z5 years.
bNo significant difference among each nation.
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onset, tremor duration and tremor severity’. Considering
the whole sample and a frequency of 32% of the allele at
risk (G), the statistical power of this association study was
80% with an assumed OR of 1.6 and 99% with an OR of 2.5
analysed by the ‘Fisher’s exact’ test. Bonferroni correction
was used because of multiple comparisons (six tests).
For linkage analysis of patients with a positive family
history, pairwise LOD scores of the Ser9Gly variant
were calculated in 22 families using the MLINK program
of the computer package FASTLINK.21,22 The disease was
considered as an autosomal-dominant trait, assuming a
penetrance of 90%, a phenocopy rate of 1%, a mutation
frequency of 0.05 and identical recombination fractions for
males and females. Patients with a possible ET were
considered as having an unknown status, whereas definite
and probably affected patients were considered as affected.
Results
Overall clinical characteristics of the three populations
studied are shown in Table 1A (familial ET) and Table 1B
(isolated non familial ET). Mean age at examination was
58.7 years (SD 16.1, range 17–91) in all ET patients and
66.9 years (SD 6.8, range 36–93) in controls with a similar
gender distribution (male/female, 176/123 and 299/229).
Tremor duration was 27.93 years (SD 16.1, range 3–69) as a
mean and the mean age of tremor onset was 29.8 years (SD
20, range 2–80) in all.
The age at tremor onset (P¼0.96) and sex ratio
(P¼0.141) were not statistically different between the
three populations. The age at examination did shown a
significant difference (P¼0.01) between the groups that
was due to the older age in the Danish sample.
Linkage and association studies
Association studies We first looked at an association of
the DRD3 variant in our ET groups. Distributions of the
genotypes in ET and control groups were in Hardy–
Weinberg equilibrium. Genotype and allele frequency of
the Gly9 allele in the whole study sample (n¼299) showed
no difference between ET patients and controls. Similarly,
in subanalyses of ET patients without (n¼97) or with a
positive family history (n¼202), no differences between ET
patients and healthy controls were found. Regarding the
largest population of patients with a positive family history
from Germany (n¼135), the same negative result was
obtained. On the contrary, the French samples with a
positive family history (n¼ 49) alone showed a slightly
significant association at both the allele and geno-
type levels (allelic P-value¼0.046 and genotypic
P-value¼0.026). After correction for multiple comparisons
the association did not remain significant (Tables 2A
and 2B).
As there was no evidence of heterogeneity between
different ethnicities (see results of w2-test in Table 3), the
already published French,10 Asian11 and American10,12
samples were added to our whole collection of ET patients.
This yielded still no significant association (Table 3).
Linkage analysis with the Ser9Gly variant in 22
families Segregation of the variant was excluded in three
families (ie, at least two patients carrying AA and GG
genotypes) and was compatible with the transmission of
the disease with allele G in 18% (n¼4, two of French
ancestry) and with allele A in 59% (n¼ 13, including 10 of
French ancestry), whereas two of the families were not
informative (Figure 1), contrasting with a previous study
showing allele G segregating in all French kindreds.10
Table 2A Genotype frequencies comparison between ET patients and controls according to the country and to family
history
Patients Genotype frequencies
Statistical
comparisona
P-value
(w2)
P-value
corrected b
AA (Ser9Ser)
(%)
AG (Ser9Gly)
(%)
GG (Gly9Gly)
(%)
Controls (German/Danish/French) (1) 248 (47) 226 (43) 54 (10) F F
All ET (German/Danish/French) (2) 131 (44) 136 (45) 32 (11) (1)–(2) 0.68
German/Danish/French ET without family
history (3)
50 (52) 37 (38) 10 (10) (1)–(3) 0.68
German/Danish/French ET with family history (4) 81 (40) 99 (49) 22 (11) (1)–(4) 0.24
(3)–(4) 0.16
German ET with family history (5) 62 (46) 59 (44) 14 (10) F F
German controls (6) 145 (47) 131 (42) 35 (11) (5)–(6) 0.94
French ET with family history (7) 12 (25) 32 (65) 5 (10) F F
French controls (8) 75 (45) 74 (45) 16 (10) (7)–(8) 0.0262 0.16b
Genotypes in both patients and controls were in Hardy–Weinberg equilibrium.
aStatistical comparison of the different numbered case/control groups.
bCorrection for multiple testing (six tests)
Bold values represents P-value o0.05
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Accordingly, linkage of the Ser9Gly variant generated a
combined pairwise LOD score of 7.16 ranging from 1.85
to þ0.67 at y¼0, when considering definite and probable
ET patients (data not shown). The entire ETM1 region
could be excluded by haplotype analysis using ETM1
flanking markers, in five families, including two of the
families with slightly positive LOD scores with the Ser9Gly
variant, thus indicating further genetic heterogeneity in
these kindreds. All of these five families were former
excluded for the ETM2 and ETM3 locus, respectively.
Correlation between genotype and clinical data
Age at onset, tremor duration and tremor severity for the
different genotypes are shown in Table 1A and 1B. When
all samples were taken into account or when analysing the
largest series of patients only, the DRD3 genotypes (AA, AG
and GG) did not affect significantly the AAO (German
sample, P¼0.786; French sample, P¼0.925), tremor dura-
tion (German sample, P¼0.255; French sample, P¼0.513)
or tremor severity (German sample, P¼0.561; French
sample, P¼ 0.98).
Discussion
In our extended study of the Ser9Gly variant of the DRD3
receptor in 299 unrelated ET patients and 528 controls
of German, French and Danish origin, no significant
differences of the genotype or allele frequencies between
cases and controls were found. As the frequency of ET cases
with a positive family history seems to be an important risk
factor for the development of the disease, we analysed the
two groups separately (n¼202 with and n¼97 without a
positive family history for ET) and found no differences
between ET cases with or without positive family histories
and controls. Only the small subset of French ET cases with
a positive family history generated a slightly statistically
significant result for the Ser9Gly variant at the allele and
genotype levels and can most likely be attributed to an
excess of heterozygotes among the cases. Surprisingly, this
Table 2B Allele frequencies comparison between ET patients and controls according to the country and family history
Patients Allele frequencies
Statistical
comparisona P-value (w2)
P-value
corrected b
A (%) G (%)
Controls (German/Danish/French) (1) 722 (68) 334 (32) F F
All ET (German/Danish/French) (2) 398 (67) 200 (33) (1)– (2) 0.45
German/Danish/French ET without family history (3) 137 (71) 57 (29) (1)– (3) 0.54
German/Danish/French ET with family history (4) 261 (65) 143 (35) (1)– (4) 0.17
(3)– (4)
German ET with family history (5) 183 (68) 87 (32) F F
German controls (6) 421 (68) 201 (32) (5)– (6) 0.97
French ET with family history (7) 56 (57) 42 (43) F F
French controls (8) 224 (68) 106 (32) (7)– (8) 0.046 0.39
Genotypes in both patients and controls were in Hardy–Weinberg equilibrium.
aStatistical comparison of the different numbered case/control groups.
bCorrection for multiple testing (six tests).
Table 3 Comparison between genotype frequencies in the present and previous studies in initial series,10 Asian 11 and
American 12 populations with familial essential tremor
Patients Genotypes (%) P-value (w2)
AA AG GG
ET patients
German/Danish/French sample 131 (44) 136 (45) 32 (11) w2¼9.342
d.f.: 8
P¼0.314
Asian sample11 72 (44) 76 (47) 15 (9)
American sample12 92 (39) 111 (47) 34 (14)
Initial French sample10 7 (23) 18 (60) 5 (17)
Initial American sample10 124 (45) 117 (42) 35 (13)
Controls
German/Danish/French sample 248 (47) 226 (43) 54 (10) w2¼13.789
d.f.: 8
P¼0.087
Asian sample11 85 (44) 87 (45) 20 (11)
American sample12 55 (45) 47 (39) 19 (16)
Initial French sample10 30 (60) 14 (28) 6 (12)
Initial American sample10 93 (51) 81 (44) 10 (5)
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result was not significant for the Gly9 homozygotes and
nevertheless was no more significant after correction for
multiple testing. This leaves open the possibility that in
some families the Ser9Gly polymorphism represents a
modifier gene but its causal role can be mostly excluded
in our series, provided that our study has 80% power to
detect an OR as small as 1.6. Furthermore, in contrast to
former studies that revealed the Gly9 allele as the risk
variant,9,10 in most French kindreds allele A was the
cosegregating allele.
Figure 1 Pedigrees of essential tremor (ET) families used in this study. Definite ET patients are represented by solid squares and circles, probable ET
by half black and possible ET by quarter black symbols, patients with unclear affection status are represented by an open symbol with a question mark
and unaffected individuals are represented by an open symbol.
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Finally, pairwise LOD scores and haplotype reconstruc-
tions in a subset of ET families of French, German and
Danish origin with the Ser9Gly variant ruled out linkage
between the DRD3 polymorphism and ET. Of note, no
other variant in the DRD3 gene was found by direct
sequencing of 52 French ET patients (data not shown). This
is in line with the results of the initial French study, where
no further non-synonymous variants, except the Ser9Gly,
and no variants in splice junctions or the promoter region
were found by sequencing a total of 5098 bp in nine
probands (n¼3 of each genotype).10
Our results are in agreement with the previous findings
in Asian and American samples.11,12 Interestingly, the
combination of both studies with ours firmly excludes an
association of the Ser9Gly polymorphism with ET (Table 3).
In addition, our results exclude linkage between this DRD3
polymorphism and ET in most informative families in
contrast to the previous report showing cosegregation in
23 out of 30 French families with ET.9,10 There is no
evidence for a selection bias, as patients originated from
various parts of France. Nevertheless and as most kindreds
shared allele A, we cannot exclude a limited number of
founders in France. Possible causes for the absence of
association and linkage in our series in contrast to the
positive result in the American ET population9,10 may be
some kind of population stratification due to a hetero-
geneous ethnic origin in the American ET population and
the consequence of the use of a larger sample mainly of
controls in our series. In addition, the AAO and the severity
of ET in our samples did not differ according to the
genotypes as shown in the previous report.10
The DRD3 gene is located within the originally described
ETM1 locus. The linkage peak markers of the ETM1 locus,
D3S1278 and D3S1267, are in 1 and 10 Mb distance from
the DRD3 gene, respectively.6 The ETM1 locus was
originally described in 16 Icelandic families, a genetic
isolate,6 and it has not been reported whether the Ser9Gly
variant cosegregates with ET in these families.
Although ET has been assumed as a familial disorder
with an apparent autosomal-dominant mode of inheri-
tance already many years ago,23 the genetic analyses of the
last 10 years showed that there is not only one simple ‘ET
gene’ but that the genetic causes of ET must be more
complex and/or heterogeneous. Recently, non-Mendelian
transmission of ET was proposed as the proportion of
affected ET patients was higher than the expected 50% in
four ET families.24 This finding is consistent with two
French families of our series, which were excluded for the
known ET loci, and in which 450% of the offspring also
suffered from ET. The reasons for these higher than
expected ratio of affected offspring might be environmen-
tal factors with phenocopies within one family, bilineal
transmission, digenic or multigenic risk accumulation with
different combinations of polymorphisms playing minor
roles or having modifying rather than causal properties.
Despite the strong familial aggregation of ET recognized
as a dominant condition, linkage studies failed to lead to
causative genes so far, which might be due to some
underlying but unrecognized clinical heterogeneity. Our
samples were assessed as consistent as possible because
only three physicians have performed the diagnosis and for
the control group individuals with advanced age were
preferred. Clinical criteria for the diagnosis of ET seem
insufficient to detect heterogeneity in families by distin-
guishing phenocopies from family-related cases. Therefore,
association studies with a candidate gene approach need to
be carefully interpreted. On the other side, genome-wide
association studies (GWAS) are able to detect small effects,
are independent of classical genetic models and take
multiple genetic and environmental factors into account.
GWAS, using better-defined ET subtypes according to
additional clinical criteria, neurophysiologic and imaging
results and treatment response orientated classifications,
might be an appropriate genetic approach to analyse a
heterogeneous disease such as ET.
In conclusion, we were not able to show neither a
significant association nor linkage of the DRD3 variant
with ET in a large number of Caucasian ET patients and
families in our samples from three different European
nations. Future GWAS with large series of ET patients will
probably constitute an appropriate method to detect
interesting regions and candidate genes involved in ET.
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